Sun, Nov 23, 2014, 3:47 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • fud.fighter2 fud.fighter2 May 18, 2014 12:58 PM Flag

    Could $13.85 today be $138.50 by next May?

    $138.50 x 48,000,000 shares would mean a valuation of $6,648,000,000.

    A valuation multiple of 9 x sales would require annual sales of $738,666,666 for that valuation.

    1. Cystic Fibrosis therapy will probably be priced upwards of $30,000 per patient per year (26 weeks on therapy).

    Target population (US and Europe): 30,000 with Pseudomonas.

    2. Therapy for TB and NTM will probably be priced around $35,000 for a six-month course.

    Target population (high-income countries): MDR-TB 30,000 / NTM 200,000.

    3. Therapy for Gram-negative pneumonia will probably be priced around $3,000 for a two-week course.

    Target population (US and Europe alone): 80,000.

    4. Just 20,000 six-month courses would mean sales of $700,000,000.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
13.52+0.28(+2.11%)Nov 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
GameStop Corp.
NYSEFri, Nov 21, 2014 4:04 PM EST
Exa Corporation
NasdaqGMFri, Nov 21, 2014 3:59 PM EST